RBC Capital Markets reiterated their positive stance on Alnylam Pharmaceuticals (NASDAQ:ALNY), maintaining an Outperform rating and a price target of $300.00. According to InvestingPro data, analyst ...

Goldman Sachs Group Inc.’s growth equity unit led a $125 million funding round for software startup Tines Security Services ...

More than 60% of the S&P-listed companies have reported earnings, and the results are well above expectations. It’s safe to ...

Employees’ privileged access to its own funds show a widening compensation gap on Wall Street. Marc Rubinstein is a former ...

Australian biopharmaceutical company CSL posted higher first-half profits as growth in its main blood-plasma business helped offset weaker flu vaccine sales, which were hit by "significantly" low ...

Illustration of the Direct Line Group logo and a rising stock graph. Banks, lawyers and advisers are set to share a £120m ...

SolarWinds is set to be acquired in a deal valued at US$4.4 billion by Turn/River Capital and will become a privately held ...

The Dow Jones Industrial Average (DJIA) dropped 444 points, or 0.99%, to 44,303, while the S&P 500 slid 0.95% to 6,026, and the Nasdaq lost 1.36% to 19,523. All three major indexes ended the week in ...

We recently compiled a list of the 10 Best Stocks to Invest in According to AI. In this article, we are going to take a look ...

SolarWinds Corporation has just announced its acquisition by Turn/River Capital in an all-cash transaction for a total ...

The rise of artificial intelligence in finance has led many investors to question whether AI-powered tools like ChatGPT can ...

Turn/River Capital has agreed to acquire SolarWinds, an Austin-based provider of observability and IT management software, in a take-private $4.4 billion deal. The sellers are Thoma Bravo and Silver ...